Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Updates
Newspaper publication of Notice in respect of proposed transfer of ordinary shares to the Investor Education and Protection Fund ('IEPF') account published in Financial Express and Andhra Prabha on April 7, 2017 is enclosed. Proceedings Of Postal Ballot
With reference to our letter dated March 24, 2017 intimating the results of the Postal Ballot conducted by the company seeking the consent of the Members for matters set forth in the Postal Ballot Notice. Please find attached the proceedings of the said Postal Ballot for your information and records. Compliance Certificate To Be Filed Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period Ended March 31St, 2017
Dear Sirs, Sub: Compliance Certificate to be filed under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Please find enclosed copy of Compliance Certificate to be filed with the Stock Exchanges under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, for the half year ended March 31st, 2017. This is for your information and records. Shareholding for the Period Ended March 31, 2017
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here Clarifies on News item
With reference to the news flashed on CNBC TV 18 dated March 30, 2015 quoting "Neuland labs close to acquiring intermediates, API facility", Neuland Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Neuland Laboratories Ltd
The Exchange has sought clarification from Neuland Laboratories Ltd on March 30, 2017, with reference to the news flashed on CNBC TV 18 dated March 30, 2015 quoting "Neuland labs close to acquiring intermediates, API facility "The reply is awaited. Clarification
With reference to increase in Volume, Neuland Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Neuland Laboratories Ltd
The Exchange has sought clarification from Neuland Laboratories Ltd on March 29, 2017, with reference to increase in Volume.The reply is awaited. Analysts / Institutional Investor Meet - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, schedule for the Analyst/Institutional Investor meetings is attached. This is for your Information and records.